On Tuesday, the team behind the plan to bring mammoth-like animals back to the tundra announced the creation of what it is ...

The ability to control gene expression across a wide range is crucial for many fields, including bioengineering, disease ...

Verve Therapeutics remains a high-reward investment despite setbacks. Click here to find out why VERV stock is a Buy.

Although plant cell-based bioproduction has advanced considerably during the past several years, certain elements remain largely unexplored.

The rise of antibiotic resistance demands urgent research into its molecular mechanisms to inform the development of ...

YolTech Therapeutics reports positive clinical data for YOLT-203, an in vivo gene editing therapy for primary hyperoxaluria type 1: Shanghai, China Wednesday, February 26, 2025, 1 ...

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR associated (Cas) systems (i.e., CRISPR/Cas) have received significant credit in modern analytical science with the capability ...

The patent describes an extremely innovative and precise method for identifying rare genetic variants within biological ...

Mayo Clinic's Precision Mouse Engineering Core in Minnesota produces CRISPR/Cas9-mediated knockout and point mutant mice for researchers.

Extinction is still forever, but scientists are trying what they say is the next best thing to restoring ancient beasts — engineering animals with qualities to resemble extinct species.